Join this Free Webinar!
On 27th March 2022, China reported 5,134 new confirmed cases of COVID-19 and 1,219 new cases of asymptomatic infection (see the latest statistics here). The new outbreak has again put China’s zero-COVID strategy to the test, and left European businesses in China facing a host of challenges – closed highways, increasing numbers of lockdowns in multiple locations, including Shanghai, and supply chain disruptions, to name just a few.
Meanwhile, the amount of approved imported vaccines on the Chinese market is zero. While trials for domestically-produced mRNA vaccines are apparently in phase 3 already, the likeliness of their widespread application let alone the efficacy remain uncertain. What is the status quo of imported vaccines in China? Will China face severe challenges before the Chinese public achieves herd immunity? With the rest of the world getting back to normal business, when will China reopen its borders? What can EU business do to safeguard operations?
To address these issues and more, the European Chamber welcomes a group of prominent speakers, led by Ambassador Chapuis, to share their insights, expertise and observations on developments and the outlook for the pandemic situation.
16:30 – 16:35 hrs Remarks by Jörg Wuttke, President, European Chamber of Commerce in China
16:35 – 17:30 hrs Insight Sharing
- HE Nicolas Chapuis, ambassador, Delegation of the European Union to China
- Dr Bernhard Schwartländer, global health envoy, German Ministry of Foreign Affairs; former chef de cabinet of Dr Tedros Adhanom Ghebreyesus, director general of the World Health Organization
- Bradley Morrison, senior vice president, Operations & Site Management Greater China, BASF Group
Terms & Conditions
Events are held in English and follow the Chatham House rule unless otherwise stated.
For further information contact Luyang Syvänen email@example.com